Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
Technology is awarded for its innovation to treat depression with NeuroStar Advanced Therapy for Mental…
Year: 2022
Healthy Extracts Reports Preliminary Q2 2022 Results
LAS VEGAS, July 13, 2022 (GLOBE NEWSWIRE) — Healthy Extracts’ (OTCQB: HYEX) reported record preliminary unaudited…
CytoDyn Appoints Cyrus Arman, Ph.D., MBA, as President
VANCOUVER, Washington, July 13, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
BioCorRx to Participate in the Benzinga All Access Event on July 15th
ANAHEIM, CA, July 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX)…
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update
FREMONT, CA, July 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations
SOUTH SAN FRANCISCO, Calif., July 13, 2022 (GLOBE NEWSWIRE) — The GBT Foundation, a 501(c)(3)…
Alimera Announces Data to Be Highlighted In Scientific Programming At Annual Congress
ILUVIEN® data to be presented onsite at the annual American Society of Retina Specialists (ASRS)…
scPharmaceuticals Inc. to Participate in the Maxim Group LLC Late-Stage Advancements in Heart Failure Therapeutics and Management Panel Discussion
BURLINGTON, Mass., July 13, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company…
Spectral Medical to Participate at the Benzinga All Access event on July 15, 2022
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
Certara Appoints Eran Broshy as New Independent Board Member
PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
NICE Issues Final Guidance for Reimbursement Making VAZKEPA® (icosapent ethyl) Available Across the NHS in England & Wales
— Newly published final guidance by the National Institute for Health and Care Excellence (NICE)…
Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management
Financing Will Significantly Strengthen the Balance Sheet and Extend Cash Runway Initial Draw of $40…
Cronos Group Inc. to Hold 2022 Second Quarter Earnings Conference Call on August 9, 2022
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”…
Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in the Emergency Department to rapidly differentiate bacterial and viral infections
Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in…
PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
Optinose Announces that XHANCE Significantly Reduced Incidence of Exacerbations for Patients with Chronic Sinusitis in Landmark ReOpen Program
XHANCE is the first and only nasal medication ever shown in Phase 3 controlled trialsto…
Plus Therapeutics to Announce Second Quarter 2022 Financial Results and Host Conference Call on July 21, 2022
AUSTIN, Texas, July 13, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial
Clinical Trial Shows Substantially Improved Bioavailiability CALGARY, Alberta, July 13, 2022 (GLOBE NEWSWIRE) — XORTX…
Revolution Medicines Appoints Lorence Kim, M.D., Accomplished Health Care Industry Leader, to Board of Directors
Board composition evolves as company’s development pipeline matures REDWOOD CITY, Calif., July 13, 2022 (GLOBE…